Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium

被引:52
作者
Crull, Katja [1 ]
Bumann, Dirk [2 ]
Weiss, Siegfried [1 ]
机构
[1] Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany
[2] Univ Basel, Bioctr, Inst Microbiol, CH-4056 Basel, Switzerland
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2011年 / 62卷 / 01期
关键词
Salmonella typhimurium; tumor colonization; virulence factors; mutants; III SECRETION SYSTEM; PATHOGENICITY ISLAND-2; TARGETED SALMONELLA; IN-VITRO; MICE; IMMUNITY; THERAPY; COLITIS; CELLS; HOST;
D O I
10.1111/j.1574-695X.2011.00790.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Administration of facultative anaerobic bacteria such as Salmonella enterica serovar Typhimurium as anticancer treatment holds a great therapeutic potential. Here, we tested different routes of application of S. typhimurium with regard to tumor colonization and therapeutic efficacy. No differences between intravenous and intraperitoneal infection were observed, often leading to a complete tumor clearance. In contrast, after oral application, tumor colonization was inefficient and delayed. No therapeutic effect was observed under such conditions. We also showed that tumor invasion and colonization were independent of functional Salmonella pathogenicity island (SPI) 1 and SPI 2. Furthermore, tumor invasion and colonization did not require bacterial motility or chemotactic responsiveness. The distribution of the bacteria within the tumor was independent of such functions.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 37 条
  • [1] Cancer immunotherapy based on killing of Salmonella-infected tumor cells
    Avogadri, F
    Martinoli, C
    Petrovska, L
    Chiodoni, C
    Transidico, P
    Bronte, V
    Longhi, R
    Colombo, MP
    Dougan, G
    Rescigno, M
    [J]. CANCER RESEARCH, 2005, 65 (09) : 3920 - 3927
  • [2] Pretreatment of mice with streptomycin provides a Salmonella enterica serovar typhimurium colitis model that allows analysis of both pathogen and host
    Barthel, M
    Hapfelmeier, S
    Quintanilla-Martínez, L
    Kremer, M
    Rohde, M
    Hogardt, M
    Pfeffer, K
    Rüssmann, H
    Hardt, WD
    [J]. INFECTION AND IMMUNITY, 2003, 71 (05) : 2839 - 2858
  • [3] Molecular interactions between dendritic cells and Salmonella:: Escape from adaptive immunity and implications on pathogenesis
    Bueno, SM
    Tobar, JA
    Iruretagoyena, MI
    Kalergis, AM
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2005, 25 (05) : 389 - 403
  • [4] Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival
    Cirillo, DM
    Valdivia, RH
    Monack, DM
    Falkow, S
    [J]. MOLECULAR MICROBIOLOGY, 1998, 30 (01) : 175 - 188
  • [5] Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium
    Clairmont, C
    Lee, KC
    Pike, J
    Ittensohn, M
    Low, KB
    Pawelek, J
    Bermudes, D
    Brecher, SM
    Margitich, D
    Turnier, J
    Li, Z
    Luo, X
    King, I
    Zheng, LM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) : 1996 - 2002
  • [6] COLEY WB, 1893, CLIN ORTHOP RELAT R, V262, P3
  • [7] One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
    Datsenko, KA
    Wanner, BL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) : 6640 - 6645
  • [8] Survivin minigene DNA vaccination is effective against neuroblastoma
    Fest, Stefan
    Huebener, Nicole
    Bleeke, Matthias
    Durmus, Tahir
    Stermann, Alexander
    Woehler, Anja
    Baykan, Bianca
    Zenclussen, Ana C.
    Michalsky, Elke
    Jaeger, Ines S.
    Preissner, Robert
    Hohn, Oliver
    Weixler, Silke
    Gaedicke, Gerhard
    Lode, Holger N.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (01) : 104 - 114
  • [9] Salmonella interactions with host cells:: in vitro to in vivo
    Finlay, BB
    Brumell, JH
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2000, 355 (1397) : 623 - 631
  • [10] Forbes NS, 2003, CANCER RES, V63, P5188